Gunot, Daizelle M.
HRN: 18-49-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2023
CEFTRIAXONE 1G (VIAL)
03/02/2023
03/08/2023
IV
900mg
OD
UTI; PCAP-B
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes